211 related articles for article (PubMed ID: 18354841)
1. Ranibizumab: new drug. Macular degeneration: second-line use due to risks.
Prescrire Int; 2008 Feb; 17(93):3-6. PubMed ID: 18354841
[TBL] [Abstract][Full Text] [Related]
2. Pegaptanib: new drug. In macular degeneration: too many risks for too little benefit.
Prescrire Int; 2006 Aug; 15(84):127-9. PubMed ID: 16989023
[TBL] [Abstract][Full Text] [Related]
3. Verteporfin: new indication. In certain age-related macular degeneration: too little evidence.
Prescrire Int; 2004 Feb; 13(69):7-9. PubMed ID: 15055207
[TBL] [Abstract][Full Text] [Related]
4. [Ranibizumab for treatment of exudative age-related macular degeneration--own experience].
Wykrota H; Gierek-Lapińska A; Trzciakowski K; Gajdzik-Gajdecka U
Klin Oczna; 2007; 109(10-12):402-9. PubMed ID: 18488382
[TBL] [Abstract][Full Text] [Related]
5. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
6. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
Ferrara N; Damico L; Shams N; Lowman H; Kim R
Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
[TBL] [Abstract][Full Text] [Related]
7. Verteporfin: new preparation. In combination with laser therapy: helpful in some forms of age-related macular degeneration.
Prescrire Int; 2001 Jun; 10(53):78-81. PubMed ID: 11718169
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic approaches to age-related macular degeneration today.
Bressler NM
Ophthalmology; 2009 Oct; 116(10 Suppl):S15-23. PubMed ID: 19800535
[TBL] [Abstract][Full Text] [Related]
9. Ranibizumab: Phase III clinical trial results.
Rosenfeld PJ; Rich RM; Lalwani GA
Ophthalmol Clin North Am; 2006 Sep; 19(3):361-72. PubMed ID: 16935211
[TBL] [Abstract][Full Text] [Related]
10. Ranibizumab and diabetic macular oedema: after laser therapy.
Prescrire Int; 2012 Mar; 21(125):66. PubMed ID: 22428185
[TBL] [Abstract][Full Text] [Related]
11. Ranibizumab for the treatment of neovascular AMD.
Kaiser PK; Do DV
Int J Clin Pract; 2007 Mar; 61(3):501-9. PubMed ID: 17313620
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
[TBL] [Abstract][Full Text] [Related]
13. [The results of wet AMD treatment by intravitreal injections--preliminary report].
Okruszko A; Borucka AI; Ulińska M; Szaflik J
Klin Oczna; 2007; 109(10-12):389-93. PubMed ID: 18488380
[TBL] [Abstract][Full Text] [Related]
14. A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration.
Brown MM; Brown GC; Brown HC; Peet J
Ophthalmology; 2008 Jun; 115(6):1039-1045.e5. PubMed ID: 17976724
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration.
Vedula SS; Krzystolik MG
Cochrane Database Syst Rev; 2008 Apr; (2):CD005139. PubMed ID: 18425911
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
[TBL] [Abstract][Full Text] [Related]
17. Monitoring ocular drug therapy by analysis of aqueous samples.
Campochiaro PA; Choy DF; Do DV; Hafiz G; Shah SM; Nguyen QD; Rubio R; Arron JR
Ophthalmology; 2009 Nov; 116(11):2158-64. PubMed ID: 19700195
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis].
Michels S; Rosenfeld PJ
Klin Monbl Augenheilkd; 2005 Jun; 222(6):480-4. PubMed ID: 15973626
[TBL] [Abstract][Full Text] [Related]
19. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
Lalwani GA; Rosenfeld PJ; Fung AE; Dubovy SR; Michels S; Feuer W; Davis JL; Flynn HW; Esquiabro M
Am J Ophthalmol; 2009 Jul; 148(1):43-58.e1. PubMed ID: 19376495
[TBL] [Abstract][Full Text] [Related]
20. Pegaptanib for neovascular age-related macular degeneration.
Maberley D
Issues Emerg Health Technol; 2005 Dec; (76):1-4. PubMed ID: 16544440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
